Juno Therapeutics, Inc. Email Format
Biotechnology ResearchWashington, United States51-200 Employees
Juno Therapeutics, Inc., a biotechnology research company, is based in Seattle, Washington. It merged with Bristol Myers Squibb to form part of a larger biopharma organization. The combined entity concentrates on discovering, developing, and delivering medicines for patients with serious diseases, including cancer. Its focus is on serving patients and healthcare providers seeking therapies for serious illnesses, with cancer as a prominent program area. The arrangement places the company within Bristol Myers Squibb’s biopharma portfolio as a mid-sized, research-driven organization.